Oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid, 2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-, (3S,11aR)-

Information Error Report

Your Email:

Browse by province 2757656-11-2 Suppliers

Global suppliers

Beijing(1)	Jiangsu(2)	Member(4)	All(4)
Henan(1)

2757656-11-2 Recommend Suppliers

Recommend You Select Member Companies...

Company Name:	Beijing Comparison Pharmaceutical Technology Co., Ltd      Recommend    Complaint
Tel:	010-010-52878169
FAX:
Email:	sales@bjcomparison.com
Products Intro:	Product Name:(3S,11aR)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid CAS:2757656-11-2 Purity:≥95% Package:100mg   More...
CB Index:	58
WebSite:	www.bjcomparison.com
Related Information:	Sales Network   Catalog(4760)   User Evaluation(4)

Company Name:	Wuxi Helen Biotechnology Co., Ltd.,      Recommend    Complaint
Tel:	0510-85629785
FAX:	0510-85625359
Email:	sales@reading-chemicals.com
Products Intro:	Product Name:(3S,11aR)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid CAS:2757656-11-2 Purity:>=95% Package:10mg;25mg;50mg;100mg;200mg;500mg   More...
CB Index:	58
WebSite:	http://www.reading-chemicals.com
Related Information:	Sales Network   Catalog(14081)   User Evaluation

Company Name:	Henan Vcommend Consultrading Co., Ltd.      Recommend    Complaint
Tel:	13393721940;
FAX:
Email:	sales@vcommend.com
Products Intro:	Product Name:Cabotegravir Impurity 10 CAS:2757656-11-2 Purity:95.0% Package:10mg;20mg;50mg   More...
CB Index:	58
WebSite:	http://www.vcommend.com/
Related Information:	Sales Network   Catalog(10005)   User Evaluation

Company Name:	TLC Pharmaceutical Standards Ltd.      Recommend    Complaint
Tel:	18012923235;
FAX:
Email:	chinasales04@tlcstandards.com.cn
Products Intro:	Product Name:Cabotegravir Impurity 10 CAS:2757656-11-2 Purity:95%+ HPLC Package:10mg;25mg;50mg;100mg   More...
CB Index:	58
WebSite:	http://www.tlcstandards.com
Related Information:	Sales Network   Catalog(4928)   User Evaluation

1